Heralding a Novel Approach in Heart Failure
Drug targeting of the molecular contractile mechanism—the sarcomere—is a novel approach to treating heart failure with reduced ejection fraction (HFrEF). This idea is gaining traction, as impaired contractility is seen as a central defect in HFrEF. However, while the science underlying this approach is well established, it isn’t widely known and is challenging to visualize clearly.
Innovative Visualization Leads to Understanding
Popular & Award Winning
The video has been used globally by three partnered pharmaceutical companies to increase awareness among clinicians. The medical communications sponsor deployed it to heart congresses (virtual and in-person), presentations, face-to-face meetings and as an online educational resource, calling the video “one of the most popular assets for our disease state education campaign.” It went on to win the Award of Excellence in Instructional Animation at the 2020 Association of Medical Illustrators annual meeting.